The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| ACHV | +6.61% | -43.57% | -10.8% | -99% |
| S&P | +16.9% | +95.99% | +14.39% | +174% |
Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver, Canada.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $0.00M | 0.0% |
| Gross Profit | -$0.06M | 3.5% |
| Market Cap | $78.39M | -51.4% |
| Market Cap / Employee | $3.14M | 0.0% |
| Employees | 25 | 13.6% |
| Net Income | -$12.72M | -50.3% |
| EBITDA | -$12.51M | -49.4% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $51.87M | 251.5% |
| Inventory | 0 | 0.0% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $8.69M | -1.2% |
| Short Term Debt | $1.27M | -85.7% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -81.50% | -22.7% |
| Return On Invested Capital | 263.18% | -7.9% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$9.07M | -84.3% |
| Operating Free Cash Flow | -$9.07M | -84.3% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 5.20 | 3.86 | 4.43 | 7.63 | 134.28% |
| Price to Tangible Book Value | 5.56 | 4.13 | 4.90 | 9.41 | 176.48% |
| Enterprise Value to EBITDA | -10.46 | -8.00 | -6.18 | -2.63 | -81.25% |
| Return on Equity | -186.0% | -409.5% | -154.5% | -120.1% | 13.36% |
| Total Debt | $9.85M | $9.96M | $9.96M | $9.96M | -43.55% |
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
